Global Contract Manufacture Organization Market Size, Status and Forecast 2025
- Id : RNR-228213
- Category : Service Industries
- Publish Date : 2018
- Pages : 108
- Format : PDF
In 2018, the global Contract Manufacture Organization (CMO) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Contract Manufacture Organization (CMO) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Contract Manufacture Organization (CMO) development in United States, Europe and China. The key players covered in this study Lonza Boehringer Ingelheim Catalent Baxter AbbVie Pfizer Evonik Fareva group Aenova Almac Delpharm Recipharm Aesica NIPRO CORPORATION Daito Pharmaceutical Teva API Esteve Quimica Euticals Zhejiang Hisun Pharmaceuticals Market segment by Type, the product can be split into Active Pharmaceutical Ingredients (APIs) Finished Dose Formulations (FDFs) Market segment by Application, split into Pharmaceutical Industry Biotechnology Medical Device Industry Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Contract Manufacture Organization (CMO) status, future forecast, growth opportunity, key market and key players. To present the Contract Manufacture Organization (CMO) development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Contract Manufacture Organization (CMO) are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.